Skip to main content

Closed

GMAB: Genmab A/S Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Revenue growth+30.7% / yr

Operating margin13.6%

ROIC8.9%

Financially safe

Strong

Debt / equity0.94×

Interest coverage7.7×

Current ratio2.18×

Valuation

Unrated

P/E ratio21.6×

Genmab A/S

GMABNASDAQ Global Select·USD·Closed

Genmab A/S

GMABNASDAQ·USD·Closed

$28.87

+0.80%

$28.87

+$0.23 (0.80%)

52W Range

55thpctl

Volume

1.06×avg

Mkt Cap

17.72BUSD

P/E

21.6TTM

Div Yield

–ann

52W Range

55thpctl

Volume

1.06×avg

Market Cap

17.72BUSD

P/E Ratio

21.6TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings